Monday, May 10, 2021

Nottingham-headquartered drug discovery company expands in the US

Sygnature Discovery, the Nottingham-headquartered drug discovery company, has established a new office presence in South San Francisco.

The new office follows Sygnature’s recent expansion in Nottingham and the opening of a second co-located integrated drug discovery site on the research campus at Alderley Park, UK.

Sygnature established its first US office in 2019 in the heart of the Cambridge–Boston biotech hub in Massachusetts, and says the new expansion will help meet growing demand from US customers ranging from major pharma through to small seed-funded biotechs.

“Our very first client was actually from the US,” said Simon Hirst, Sygnature’s CEO and founder. “It remains a very significant market for us, both now and in our future strategy. It’s fantastic to have a base on the west coast, and in such a vibrant hub for the life sciences community.

“Our approach to drug discovery is based on true collaboration and partnership with our clients, and having a physical presence near to many of them helps us to work the way we believe in – strengthening those ties and relationships that lead to success.”

The new office is located on Gateway Boulevard, Oyster Point, in South San Francisco.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.






Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close